Skip to main content
. 2021 May 24;8:687149. doi: 10.3389/fmed.2021.687149

Table 1.

Baseline characteristics of patients with MG stratified by the status of kidney injury.

Characteristic Overall (n = 1,164) With kidney injury (n = 782) Without kidney injury (n = 382) P
Male 711 (61.1%) 481 (61.5%) 230 (60.2%) 0.669
Age (year) 61.2 ± 12.4 62.1 ± 12.3 59.4 ± 12.5 0.001
Hypertension 290 (24.9%) 231 (29.5%) 59 (15.4%) <0.001
Diabetes 120 (10.3%) 90 (11.5%) 30 (7.9%) 0.054
Hepatitis B 35 (3.0%) 25 (3.2%) 10 (2.6%) 0.587
Serum studies
    Albumin (g/l) 31.2 ± 7.4 29.9 ± 7.5 33.8 ± 6.3 <0.001
    Creatinine (μmo/l) 166.3 ± 268.2 216.1 ± 315.3 64.3 ± 16.8 <0.001
    eGFR (ml/min per 1.73 m2) 71.4 ± 36.7 58.5 ± 36.8 97.8 ± 17.1 <0.001
    eGFR <60 (ml/min per 1.73 m2) 401 (34.5%) 401 (51.3%) 0 (0) <0.001
    κ/λ 1.81 (0.70–7.42) 1.71 (0.70–6.08) 2.10 (0.80–9.81) 0.543
Urinary studies
    Urinary protein (g/d) 0.82 (0.20–3.04) 1.44 (0.35–4.15) 0.11 (0.07–0.15) <0.001
    Proteinuria >1.5 g/d 166 (39.6%) 166 (48.0%) 0 (0) <0.001
    Hematuria 407 (38.8%) 407 (56.3%) 0 (0) <0.001
    κ/λ 1.42 (0.49–2.68) 1.42 (0.49–2.68) / /
Hematologic studies
Clonal subtype
Ig isotype
    IgA(+) 305 (26.2%) 212 (27.1%) 93 (24.3%) 0.314
    IgG(+) 638 (54.8%) 416 (53.2%) 222 (58.1%) 0.113
    IgM(+) 128 (11.0%) 78 (10.0%) 50 (13.1%) 0.111
    IgA/IgG/IgM(+) 19 (1.6%) 14 (1.8%) 5 (1.3%) 0.543
    IgA&IgG&IgM(−) 74 (6.4%) 62 (7.9%) 12 (3.1%) 0.002
Ig light chain
    Kappa(+) 498 (42.8%) 321 (41.0%) 177 (46.3%) 0.087
    Lambda(+) 480 (41.2%) 333 (42.6%) 147 (38.5%) 0.182
    Kappa&Lambda(+) 20 (1.7%) 12 (1.5%) 8 (2.1%) 0.49
    Kappa&Lambda(−) 166 (14.3%) 116 (14.8%) 50 (13.1%) 0.424
Received BM biopsy 377 (29.0%) 261 (33.4%) 76 (19.9%) <0.001

Values for continuous variables are described as mean ± SD or median (IQR) depending on the distribution, and for categoric variables described as count (%).